Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York exposures and breast cancer (WEB) study

Cancer Causes and Control

Volumn 21, Issue 9, 2010, Pages 1503-1512

  Brasky, Theodore M ^a   Bonner, Matthew R ^a   Moysich, Kirsten B ^b   Ambrosone, Christine B ^b   Nie, Jing ^a   Tao, Meng Hua ^a   Edge, Stephen B ^b   Kallakury, Bhaskar V S ^c   Marian, Catalin ^c   Trevisan, Maurizio ^d   Shields, Peter G ^c   Freudenheim, Jo L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d Nevada System of Higher Education   (United States)

Author keywords

Aspirin; Breast cancer; Ibuprofen; Inflammation; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; PARACETAMOL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK REDUCTION; UNITED STATES;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEW YORK; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS;

EID: 77956969905     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9579-5     Document Type: Article

References (49)

1. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 6917 860 867 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D 12490959
2. RE Harris J Beebe-Donk H Doss D Burr-Doss 2005 Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade Oncol Rep 13 559 583 1:CAS:528: DC%2BD2MXjtFans74%3D 15756426
3. G Singh-Ranger K Mokbel 2002 The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition Eur J Surg Oncol 28 7 729 737 10.1053/ejso.2002.1329 1:STN:280:DC%2BD38nntFWisg%3D%3D 12431470
4. RW Brueggemeier ES Diaz-Cruz P-K Li Y Sugimoto YC Lin CL Shapiro 2005 Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer J Steroid Biochem Mol Biol 95 1-5 129 136 10.1016/j.jsbmb.2005.04. 013 1:CAS:528:DC%2BD2MXntVOhtLY%3D 15964185
5. PF Coogan SR Rao L Rosenberg JR Palmer BL Strom AG Zauber PD Stolley S Shapiro 1999 The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer Prev Med 29 2 72 76 10.1006/pmed.1999.0518 1:CAS:528:DyaK1MXltV2hsL8%3D 10446030
6. RE Harris K Namboodiri SD Stellman EL Wynder 1995 Breast cancer and NSAID use: heterogeneity of effect in a case-control study Prev Med 24 2 119 120 10.1006/pmed.1995.1022 1:STN:280:DyaK2MzitVWgsw%3D%3D 7597011
7. RE Harris KK Namboodiri WB Farrar 1996 Nonsteroidal antiinflammatory drugs and breast cancer Epidemiology 7 2 203 205 10.1097/00001648-199603000- 00017 1:STN:280:DyaK28vjtFCrsw%3D%3D 8834563
8. CR Sharpe JP Collet M McNutt E Belzile JF Boivin JA Hanley 2000 Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage Br J Cancer 83 1 112 120 10.1054/bjoc.2000.1119 1:CAS:528:DC%2BD3cXkvFOgtrw%3D 10883678
9. Cotterchio M, Kreiger N, Sloan M, Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10(11):1213-1217
10. CR Meier S Schmitz H Jick 2002 Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer Pharmacotherapy 22 3 303 309 10.1592/phco.22.5.303.33189 1:CAS:528:DC%2BD38XisVagsbw%3D 11898889
11. PG Moorman JM Grubber RC Millikan B Newman 2003 Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast Cancer Causes Control 14 10 915 922 10.1023/B:CACO.0000007973.59863.66 14750530
12. LA Garcia Rodriguez A Gonzalez-Perez 2004 Risk of breast cancer among users of aspirin and other anti-inflammatory drugs Br J Cancer 91 3 525 529 10.1038/sj.bjc.6602003 1:CAS:528:DC%2BD2cXlvF2ltro%3D 15226764
13. Terry MB, Gammon MD, Zhang FF, Tawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291(20):2433-2440
14. E Rahme J Ghosn K Dasgupta R Rajan M Hudson 2005 Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer BMC Cancer 5 159 10.1186/1471-2407-5-159 16343343
15. H Swede AL Mirand RJ Menezes KB Moysich 2005 Association of regular aspirin use and breast cancer risk Oncology 68 1 40 47 10.1159/000084818 1:CAS:528:DC%2BD2MXjslCgtbs%3D 15802928
16. Y Zhang PF Coogan JR Palmer BL Strom L Rosenberg 2005 Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the case-control surveillance study revisited Am J Epidemiol 162 2 165 170 10.1093/aje/kwi182 15972932
17. RE Harris J Beebe-Donk GA Alshafie 2006 Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors BMC Cancer 6 27 10.1186/1471-2407-6-27 16445867
18. Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Canc Inst 88(14):988-993
19. S Friis HT Sorensen JK McLaughlin SP Johnsen WJ Blot JH Olsen 2003 A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin Br J Cancer 88 684 688 10.1038/sj.bjc.6600760 1:STN:280:DC%2BD3s7gsFWlsQ%3D%3D 12618874
20. RE Harris RT Chlebowski RD Jackson DJ Frid JL Ascenseo G Anderson A Loar RJ Rodabough E White A McTiernan Women's Health I 2003 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative Cancer Res 63 18 6096 6101 1:CAS:528:DC%2BD3sXnvVSitb8%3D 14522941
21. RE Harris S Kasbari WB Farrar 1999 Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer Oncol Rep 6 1 71 73 1:CAS:528:DyaK1MXkt1SjtA%3D%3D 9864404
22. Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomarkers Prev 11(12):1586-1591
23. Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5(2):138-146
24. HT Sorensen S Friis B Norgard L Mellemkjaer WJ Blot JK MacLaughlin A Ekbom JA Baron 2003 Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study Br J Cancer 88 11 1687 1692 10.1038/sj.bjc.6600945 1:CAS:528:DC%2BD3sXktVentLo%3D 12771981
25. S Friis L Thomassen HT Sorensen A Tjonneland K Overvad DP Cronin-Fenton U Vogel JK McLaughlin WJ Blot JH Olsen 2008 Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study Eur J Cancer Prev 17 2 88 96 10.1097/CEJ.0b013e3282b6fd55 18287865
26. L Gallicchio K Visvanathan A Burke SC Hoffman KJ Helzlsouer 2007 Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD Int J Cancer 121 1 211 215 10.1002/ijc.22656 1:CAS:528:DC%2BD2sXlsVajs7Y%3D 17330846
27. GL Gierach JV Lacey Jr A Schatzkin MF Leitzmann D Richesson AR Hollenbeck LA Brinton 2008 Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP diet and health study Breast Cancer Res 10 2 R38 10.1186/bcr2089 18447943
28. J Gill G Maskarinec LR Wilkens MC Pike BE Henderson LN Kolonel 2007 Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort Am J Epidemiol 166 10 1150 1158 10.1093/aje/kwm195 17698973
29. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE (2007) A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Canc Inst 99(8):608-615
30. Jacobs EJ, Thun MJ, Connell CJ, Rodriguez C, Henley SJ, Feigelson HS, Patel AV, Flanders WD, Calle EE (2005) Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large US cohort. Cancer Epidemiol Biomarkers Prev 14(1):261-264
31. SF Marshall L Bernstein H Anton-Culver D Deapen PL Horn-Ross H Mohrenweiser D Peel R Pinder DM Purdie P Reynolds D Stram D West WE Wright A Ziogas RK Ross 2005 Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status J Natl Cancer Inst 97 11 805 812 10.1093/jnci/dji140 1:CAS:528:DC%2BD2MXkvVShtbY%3D 15928301
32. AH Eliassen WY Chen D Spriegelman WC Willet DJ Hunter SE Hankinson 2009 Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the nurses' health study II Arch Intern Med 169 2 115 121 10.1001/archinternmed.2008.537 19171806
33. A Ready CM Velicer A McTiernan E White 2008 NSAID use and breast cancer risk in the VITAL cohort Breast Cancer Res Treat 109 533 543 10.1007/s10549-007-9665-x 1:CAS:528:DC%2BD1cXlvVCgtrY%3D 17674199
34. B Takkouche C Regueira-Mendez M Etminan 2008 Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis J Natl Cancer Inst 100 20 1420 1423 10.1093/jnci/djn347
35. NR Cook IM Lee JM Gaziano D Gordon PM Ridker JE Manson CH Hennekens JE Buring 2005 Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial J Am Med Assoc 294 1 47 55 10.1001/jama.294.1.47 1:CAS:528:DC%2BD2MXlvVKnt7Y%3D
36. Burke A, Smyth E, FitzGerald GA (2006) Analgesic-antipyretic agents; pharmacotherapy of Gout. In: Brunton LL, Lazlo JS, Parker KL (eds) Goodman & Gilman's the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 671-716
37. Bonner MR, Han D, Nie J, Rogerson P, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL (2005) Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 14(1):53-60
38. MR Bonner J Nie D Han JE Vena P Rogerson P Muti M Trevisan SB Edge JL Freudenheim 2005 Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States) Cancer Causes Control 16 6 683 689 10.1007/s10552-005-1906-x 16049807
39. McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL (2004) Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiol Biomarkers Prev 13(9):1480-1484
40. D Han J Nie MR Bonner SE McCann P Muti M Trevisan FA Ramirez-Marrero D Vito JL Freudenheim 2006 Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study Int J Cancer 119 12 2931 2937 10.1002/ijc.22236 1:CAS:528:DC%2BD28Xht1yqt7nI 17016824
41. EV Hersh PA Moore GL Ross 2000 Over-the-counter analgesics and antipyretics: a critical assessment Clinical Therapeutics 22 5 500 548 10.1016/S0149-2918(00)80043-0 1:CAS:528:DC%2BD3cXksVCrtrY%3D 10868553
42. SN O'Brien J Anandjiwala TM Price 1997 Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use Obstet Gynecol 90 2 244 248 10.1016/S0029-7844(97)00212-3 9241302
43. CS Lieber 2004 Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis Alcohol 34 1 9 19 10.1016/j.alcohol. 2004.07.008 1:CAS:528:DC%2BD2MXmvFOhsw%3D%3D 15670660
44. G Davies LA Martin N Sacks M Dowsett 2002 Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention Ann Oncol 13 5 669 678 10.1093/annonc/mdf125 1:STN:280:DC%2BD38zjtlWkug%3D%3D 12075734
45. LR Howe S-H Chang KC Tolle R Dillon LJT Young RD Cardiff RA Newman P Yang HT Thaler WJ Muller C Hudis AMC Brown T Hla K Subbaramaiah AJ Dannenberg 2005 HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice Cancer Res 65 21 10113 10119 10.1158/0008-5472. CAN-05-1524 1:CAS:528:DC%2BD2MXhtFKkt7vO 16267038
46. RA Karmali J Marsh C Fuchs 1984 Effect of omega-3 fatty acids on growth of a rat mammary tumor J Natl Cancer Inst 73 2 457 461 1:CAS:528: DyaL2cXlt12nsro%3D 6087007
47. WJ Kort IM Weijma AM Bijma WP van Schalkwijk AJ Vergroesen DL Westbroek 1987 Omega-3 fatty acids inhibiting the growth of a transplantable rat mammary adenocarcinoma J Natl Cancer Inst 79 3 593 599 1:CAS:528:DyaL2sXmtFKmuro%3D 3476794
48. CH Liu SH Chang K Narko OC Trifan MT Wu E Smith C Haudenschild TF Lane T Hla 2001 Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice J Biol Chem 276 21 18563 18569 10.1074/jbc.M010787200 1:CAS:528:DC%2BD3MXktFWmtbc%3D 11278747
49. Shiff SJ, Rigas B. (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 190(4):445-450